Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor

Laprairie, R B, Bagher, A M, Kelly, M E M, Denovan‐Wright, E M·2015·British Journal of Pharmacology

DOI 10.1111/bph.13250

Cited by (1,000)

Items 201–300 of 1,000

A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors
Carolina Echeverry, Giselle Prunell, Camila Narbondo, Verónica Sánchez de Medina, Xavier Nadal, Miguel Iván Reyes-Parada, Cecilia Scorza · 2020 · Neurotoxicity Research
Advancing the science on cannabis concentrates and behavioural health
L. Cinnamon Bidwell, Renée Martin‐Willett, Hollis C. Karoly · 2021 · Drug and Alcohol Review
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity
Oliver Grimm, Martin Löffler, Sandra Kamping, Aljoscha Hartmann, Cathrin Rohleder, F. Markus Leweke, Herta Flor · 2018 · European Neuropsychopharmacology
A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age
Michelle Sexton, Carrie Cuttler, Laurie K. Mischley · 2018 · The Journal of Alternative and Complementary Medicine
Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process
Karim Shiraz Ladha, Alexander McLaren-Blades, Akash Goel, Michael Jacob Buys, Paul W. Farquhar-Smith, Simon Haroutounian, Yuvaraj Kotteeswaran, Kwesi Kwofie, Bernard Le Foll, Nicholas J. Lightfoot et al. · 2020 · British Journal of Anaesthesia
Cannabis in Parkinson’s Disease: The Patients’ View
Ferhat Yenilmez, Odette Fründt, Ute Hidding, Carsten Buhmann · 2020 · Journal of Parkinson s Disease
Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study
Lara Bapir, Simon Erridge, Martha Nicholas, Manaswini Pillai, Nishaanth Dalavaye, Carl Holvey, Ross Coomber, Jonathan M. Hoare, Shaheen Ali Khan, Mark W. Weatherall et al. · 2023 · Expert Review of Neurotherapeutics
Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils
Slavko Komarnytsky, R. Thirumurugan, Charles Wagner, Brandon Troy Metzger, Carolina Carlisle, Chinmayee Panda, Sara Le Brun-Blashka, JOHN P. TROUP, Saradhadevi Varadharaj · 2021 · International Journal of Molecular Sciences
TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids
Kathleen Louis-Gray, Srinivasan Tupal, Louis S. Premkumar · 2022 · International Journal of Molecular Sciences
Review of the oral toxicity of cannabidiol (CBD)
Jeremy Gingrich, Supratim Choudhuri, Patrick Cournoyer, Jason Downey, Kristi Muldoon Jacobs · 2023 · Food and Chemical Toxicology
CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim
Sales, Amanda J., Guimarães, Francisco S., Joca, Sâmia R.L. · 2020 · Behavioural Brain Research
Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment
E. Aso, V. Fernández-Dueñas, Marc López-Cano, J. Taura, M. Watanabe, I. Ferrer, R. Luján, F. Ciruela · 2019 · Molecular Neurobiology
The microbiome and gut endocannabinoid system in the regulation of stress responses and metabolism
Srivastava, Raj Kamal, Lutz, Beat, Ruiz de Azua, Inigo · 2022 · Frontiers in Cellular Neuroscience
Cannabinoids as hippocampal network administrators
Carl R. Lupica, Yuhan Hu, Orrin Devinsky, Alexander F. Hoffman · 2017 · Neuropharmacology
Emerging strategies targeting CB2 cannabinoid receptor: Biased agonism and allosterism
Paula Morales, Pilar Goya, Nadine Jagerovic · 2018 · Biochemical Pharmacology
Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels
Han-Xiong Bear Zhang, Bruce P. Bean · 2021 · Journal of Neuroscience
Endocannabinoid signaling in the central nervous system
César E. Martinez Ramirez, Gonzalo Ruiz‐Pérez, Todd M. Stollenwerk, Christina Behlke, Ashley Doherty, Cecilia J. Hillard · 2022 · Glia
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, Carmen-Maria Rusz, Amelia Tero-Vescan, Amalia Puşcaş · 2023 · Antioxidants
Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study
Andrew A. Monte, Diane P. Calello, Roy R. L. Gerona, Eike Hamad, Sharan L. Campleman, Jeffery Brent, Paul M. Wax, Robert Gideon Carlson · 2017 · Journal of Medical Toxicology
Quantification of the content of cannabidiol in commercially available e-liquids and studies on their thermal and photo-stability
Carlo Mazzetti, Emanuele Ferri, Monica Pozzi, Massimo Labra · 2020 · Scientific Reports
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Lara Senn, Giuseppe Cannazza, Giuseppe Biagini · 2020 · Pharmaceuticals
Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids
Giulia Martinelli, Andrea Magnavacca, Marco Fumagalli, Mario Dell’Agli, Stefano Piazza, Enrico Sangiovanni · 2021 · Planta Medica
Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training
Eduard Isenmann, Sebastian Veit, Lynn Starke, Ulrich Flenker, Patrick Rene Diel · 2021 · Nutrients
Cannabinoids and the eye
Michael T.M. Wang, Helen Victoria Danesh-Meyer · 2020 · Survey of Ophthalmology
Differentiating Cannabis Products: Drugs, Food, and Supplements
Arash Salehi, Keely Puchalski, Yalda Shokoohinia, Behzad Zolfaghari, Sedigheh Asgary · 2022 · Frontiers in Pharmacology
Species‐specific susceptibility to cannabis‐induced convulsions
Benjamin J. Whalley, Hong Lin, Lynne Bell, Thomas Hill, Amesha Patel, Roy Gray, Claire Roberts, Orrin Devinsky, Michaël Bazelot, Claire Michelle Williams et al. · 2018 · British Journal of Pharmacology
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia
Ashleigh L. Osborne, Nadia Solowij, Ilijana Babic, Jeremy Stephen Lum, Kelly Anne Newell, Xu‐Feng Huang, Katrina Weston–Green · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
F. Markus Leweke, Cathrin Rohleder, C.W. Gerth, Martin Hellmich, Ralf Pukrop, Dagmar Koethe · 2021 · Frontiers in Pharmacology
Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes
Sera Sermet, Jinpeng Li, Anthony P. Bach, Robert B. Crawford, Norbert E. Kaminski · 2021 · Toxicology
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
Kevin F. Boehnke, Winfried Häuser, Mary‐Ann Fitzcharles · 2022 · Current Rheumatology Reports
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
João Francisco Cordeiro Pedrazzi, Frederico Rogério Ferreira, Danyelle Silva-Amaral, Daniel de Alencar Lima, Jaime E. C. Hallak, Antônio Waldo Zuardi, Elaine Aparecida Del Bel, Francisco Silveira Guimarães, Karla Cristinne Mancini Costa, Alline Cristina Campos et al. · 2022 · Psychopharmacology
Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy
Keti Bardhi, Shelby Coates, Christy J.W. Watson, Philip J. Lazarus · 2022 · Expert Review of Clinical Pharmacology
Cannabinoid treatments in epilepsy and seizure disorders
Orrin Devinsky, Nicholas A. Jones, Mark O. Cunningham, Bodiabaduge A. P. Jayasekera, Sasha Devore, Benjamin J. Whalley · 2023 · Physiological Reviews
Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model
Robert B. Laprairie, Amina M. Bagher, Jillian L. Rourke, Adel Zrein, Elizabeth A. Cairns, Melanie E.M. Kelly, Christopher J. Sinal, Pushkar M. Kulkarni, Ganesh A. Thakur, Eileen M. Denovan‐Wright · 2019 · Neuropharmacology
Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience
Mojdeh Mostafavi, John N. Gaitanis · 2020 · Seminars in Pediatric Neurology
Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System
Patrícia Schönhofen, Ivi Juliana Bristot, José Alexandre S. Crippa, Jaime E. C. Hallak, Antônio Waldo Zuardi, Richard B. Parsons, Fábio Klamt · 2018 · CNS Drugs
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
Julia de Ternay, Mickaël Naassïla, Mikaïl Nourredine, Alexandre Louvet, François Bailly, Guillaume Sescousse, Pierre Maurage, Olivier Cottencin, Patrizia Carrieri, Benjamin Rolland · 2019 · Frontiers in Pharmacology
Cannabinoid concentrations in blood and urine after smoking cannabidiol joints
Ulf Meier, Franz E. Dussy, Eva Scheurer, Katja Mercer‐Chalmers‐Bender, Sarah Hangartner · 2018 · Forensic Science International
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
Nilson Carlos Ferreira‐Junior, Maurício dos Santos Pereira, Francisco Silveira Guimarães, Elaine Del Bel · 2019 · Neurotoxicity Research
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya · 2020 · Frontiers in Psychology
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Ewa Galaj, Zheng‐Xiong Xi · 2020 · International Journal of Molecular Sciences
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
Natalia Brzozowska, Kong M. Li, Xiaosuo Wang, Jessica Booth, Jordyn M. Stuart, Iain S. McGregor, Jonathon Carl Arnold · 2016 · PeerJ
Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
Ricardo Ernesto Ramírez-Orozco, Ricardo García-Ruiz, Paula Morales, Carlos M. Villalón, José Rafael Villafán-Bernal, Bruno A. Marichal‐Cancino · 2019 · Current Neuropharmacology
Impacts of cannabinoid epigenetics on human development: reflections on Murphy et. al. ‘cannabinoid exposure and altered DNA methylation in rat and human sperm’ epigenetics 2018; 13: 1208-1221.
Albert Stuart Reece, Gary Kenneth Hulse · 2019 · Epigenetics
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders
Ashleigh L. Osborne, Nadia Solowij, Ilijana Babic, Jeremy Stephen Lum, Xu‐Feng Huang, Kelly Anne Newell, Katrina Weston–Green · 2019 · Brain Behavior and Immunity
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares, María S. García‐Gutiérrez, Lucía Illescas, Ani Gasparyan, Jorge Manzanares · 2022 · Pharmaceuticals
The effect of a mixed cannabidiol and cannabidiolic acid based oil on client‐owned dogs with atopic dermatitis
Melissa Loewinger, Joseph J. Wakshlag, Daniel Bowden, Jeanine Peters‐Kennedy, Andrew Rosenberg · 2022 · Veterinary Dermatology
CBD and THC: Do They Complement Each Other Like Yin and Yang?
Sarah D. Pennypacker, Edgar Alfonso Romero-Sandoval · 2020 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, Cristina Miliano · 2023 · International Journal of Molecular Sciences
Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics
Rui Filipe Malheiro, Helena Carmo, Félix Dias Carvalho, João Pedro Silva · 2022 · Pharmacological Research
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
F. Markus Leweke, Juliane K. Mueller, Bettina Lange, Stefan Fritze, Cristina E. Topor, Dagmar Koethe, Cathrin Rohleder · 2018 · CNS Drugs
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Matthew E. Sloan, Caroline W. Grant, Joshua L. Gowin, Vijay A. Ramchandani, Bernard Le Foll · 2018 · Acta Pharmacologica Sinica
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg · 2022 · Biomedicines
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Uri Bright, Irit Akirav · 2022 · International Journal of Molecular Sciences
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Grace Tsz Yan Yau, Waiting Tai, Jonathon Carl Arnold, Hak‐Kim Chan, Philip Chi Lip Kwok · 2023 · Pharmaceutical Research
A Review of the Therapeutic Antitumor Potential of Cannabinoids
Višnja Bogdanović, Jasminka Mrdjanović, Ivana Đ. Borišev · 2017 · The Journal of Alternative and Complementary Medicine
Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential
Tomáš Pluskal, Jing‐Ke Weng · 2017 · Chemical Society Reviews
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
Dai Lu, Sri Sujana Immadi, Zhixing Wu, Debra A. Kendall · 2018 · Acta Pharmacologica Sinica
Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
Cecilia Theresa Costiniuk, Zahra Saneei, Jean‐Pierre Routy, Shari L. Margolese, Enrico Mandarino, Joel Singer, Bertrand Lebouché, Joseph Cox, Jason Szabo, Marie‐Josée Brouillette et al. · 2019 · BMJ Open
Cannabidiol inhibits sucrose self‐administration by CB 1 and CB 2 receptor mechanisms in rodents
Guo‐Hua Bi, Ewa Galaj, Yi He, Zheng‐Xiong Xi · 2019 · Addiction Biology
Evaluation of pharmacokinetics and acute anti‐inflammatory potential of two oral cannabidiol preparations in healthy adults
Jack M. Hobbs, Allegra R. Vazquez, Nicholas D. Remijan, Roxanne E. Trotter, Gear Thomas Vincent, Kimberly E. Freedman, Yuren Wei, Keith A. Woelfel, Olivia R. Arnold, Lisa M. Wolfe et al. · 2020 · Phytotherapy Research
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
Catalina Pérez-Olives, Rafael Rivas‐Santisteban, Jaume Lillo, Gemma Navarro, Rafael Franco · 2020 · Advances in experimental medicine and biology
Cannflavins—From plant to patient: A scoping review
Erridge, Simon, Mangal, Nagina, Salazar, Oliver, Pacchetti, Barbara, Sodergren, Mikael H. · 2020 · Fitoterapia
Differential regulation of Ca v 3.2 and Ca v 2.2 calcium channels by CB 1 receptors and cannabidiol
Erika K. Harding, Ivana Assis Souza, María A. Gandini, Vinícius M. Gadotti, Md Yousof Ali, Sun Huang, Flavia Tasmin Techera Antunes, Tuan Trang, Gerald Werner Zamponi · 2023 · British Journal of Pharmacology
Does cannabidiol have a role in the treatment of schizophrenia?
Anand Gururajan, Daniel T. Malone · 2016 · Schizophrenia Research
Is there a role for cannabidiol in psychiatry?
Júlia Machado Khoury, Maila de Castro Lourenço das Neves, Marco Antônio Valente Roque, Daniela Alves de Brito Queiroz, André Augusto Corrêa de Freitas, Ângelo de Fátima, Fabrício A. Moreira, Frederico Duarte Garcia · 2017 · The World Journal of Biological Psychiatry
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
R. Rodrigues, D. Lourenço, S. Paulo, J. Mateus, M. A. Ferreira, Francisco M. Mouro, J. B. Moreira, F. Ribeiro, A. Sebastião, S. Xapelli · 2019 · Molecules
The effectiveness of self-directed medical cannabis treatment for pain
Xiaoxue Li, Jacob Miguel Vigil, Sarah See Stith, Franco Brockelman, Keenan Keeling, Branden Hall · 2019 · Complementary Therapies in Medicine
Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol
Cristian Bis‐Humbert, Rubén García‐Cabrerizo, María Julia García-Fuster · 2020 · Psychopharmacology
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
Anastasia S. Suraev, Ronald R. Grunstein, Nathaniel S. Marshall, Angela L. D'Rozario, Christopher James Gordon, Delwyn J. Bartlett, KEITH K. H. WONG, Brendon John Yee, Ryan G. Vandrey, Christopher G. Irwin et al. · 2020 · BMJ Open
Prospects for the Use of Cannabinoids in Psychiatric Disorders
Michał Graczyk, Małgorzata Łukowicz, Tomasz Dzierżanowski · 2021 · Frontiers in Psychiatry
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol
Gemma Navarro, Ángel González, Adrià Sánchez-Morales, Nil Casajuana-Martín, Marc Gómez-Ventura, Arnau Cordomí, Félix Busquè, Ramón Alibés, Leonardo Pardo, Rafael Franco · 2021 · Journal of Medicinal Chemistry
Cannabidiol and substance use disorder: Dream or reality
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, Andrew F. Scheyer, Olivier J. Manzoni, Abbas Haghparast · 2022 · Neuropharmacology
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Stephanie L. Bourke, Anne Katrin Schlag, Saoirse Elizabeth O’Sullivan, David Nutt, David P. Finn · 2022 · Pharmacology & Therapeutics
Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus
Viviana di Giacomo, Annalisa Chiavaroli, Giustino Orlando, Amelia Cataldi, Monica Rapino, Valentina Di Valerio, Sheila Leone, Luigi Brunetti, Luigi Menghini, Lucia Recinella et al. · 2020 · Antioxidants
Interactions between cannabidiol and Δ 9 ‐tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome
Lyndsey L. Anderson, Ivan K. Low, Iain S. McGregor, Jonathon Carl Arnold · 2020 · British Journal of Pharmacology
Approved cannabinoids for medical purposes – Comparative systematic review and meta-analysis for sleep and appetite
Spanagel, Rainer, Bilbao, Ainhoa · 2021 · Neuropharmacology
Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review
Graziella Madeo, Ashita Kapoor, Raffaele Giorgetti, Francesco Paolo Busardò, Jérémy Carlier · 2023 · Current Neuropharmacology
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
Jakub Jakowiecki, Renata Abel, Urszula Orzeł, Paweł Pasznik, Robert Preißner, Sławomir Filipek · 2021 · Molecules
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, Mădălina Larion, Walther Bild, Gabriela Dumitriţa Stanciu, Carmen Solcan, Veronica Bild · 2022 · Biology
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco‐2 cells
Stefano Gigli, Luisa Seguella, Marcella Pesce, Eugenia Bruzzese, Alessandra D’Alessandro, Rosario Cuomo, Luca Steardo, Giovanni Sarnelli, Giuseppe Esposito · 2017 · United European Gastroenterology Journal
Evidence for the use of cannabinoids in Parkinson’s disease
Carsten Buhmann, Tina Mainka, Georg Ebersbach, Florin Gandor · 2019 · Journal of Neural Transmission
Biological bases for a possible effect of cannabidiol in Parkinson’s disease
Nilson Carlos Ferreira‐Junior, Alline Cristina Campos, Francisco Silveira Guimarães, Elaine Aparecida Del Bel, Patrícia Moura da Rosa Zimmermann, Liberato Brum, Jaime E. C. Hallak, José Alexandre S. Crippa, Antônio Waldo Zuardi · 2019 · Brazilian Journal of Psychiatry
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, Mireia Casanovas, Catalina Pérez-Olives, Carlos Ferreiro‐Vera, Gemma Navarro, Verónica Sánchez de Medina, Xavier Nadal · 2020 · Pharmacological Research
Palmitoylethanolamide: A Potential Alternative to Cannabidiol
Paul Clayton, Silma Subah, Ruchitha Venkatesh, Mariko Hill, Nathasha Omal Bogoda · 2021 · Journal of Dietary Supplements
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
Chesney, Edward, Oliver, Dominic, McGuire, Philip · 2022 · Psychopharmacology
Cannabis and Athletic Performance
Jamie F. Burr, Christian P. Cheung, Andreas M. Kasper, Scott H. Gillham, Graeme Leonard Close · 2021 · Sports Medicine
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Stuart M. Brierley, Beverley Greenwood–Van Meerveld, Giovanni Sarnelli, Keith A. Sharkey, Martin Storr, Jan F. Tack · 2022 · Nature Reviews Gastroenterology & Hepatology
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations
Abdel-ilah Aziz, Long C. Nguyen, Loubna Oumeslakht, Armand Bensussan, Sanae Ben Mkaddem · 2022 · Cannabis and Cannabinoid Research
Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds
Brittney R. Lins, Chidozie C. Anyaegbu, Sarah C. Hellewell, Melissa G. Papini, Terence A. McGonigle, Luca De Prato, Matthew Shales, Melinda Fitzgerald · 2023 · Journal of Neuroinflammation
Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Angelika Andrzejewska-Romanowska, Klaudia Staszak, Magdalena Hryhorowicz, Aleksandra Korcz, Ryszard Słomski · 2019 · International Journal of Molecular Sciences
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Edward Chesney, Philip K. McGuire, Tom P. Freeman, John Strang, Amir Englund · 2020 · Therapeutic Advances in Psychopharmacology
Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments
Marco Mori, Erika Meyer, Francielly F. da Silva, Humberto Milani, Francisco Silveira Guimarães, Rúbia Maria Weffort de Oliveira · 2021 · European Journal of Neuroscience
Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · International Journal of Molecular Sciences
UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions
Michael Harris, Simon Erridge, Mehmet Ergisi, Devaki Nimalan, Michal Kawka, Oliver Salazar, Rayyan Ali, Katerina Loupasaki, Carl Holvey, Ross Coomber et al. · 2021 · Expert Review of Clinical Pharmacology
Assessment of spent hemp biomass as a potential ingredient in ruminant diet: nutritional quality and effect on performance, meat and carcass quality, and hematological parameters in finishing lambs
Nathan B. Parker, Massimo Bionaz, Hunter R. Ford, Agung Irawan, Erminio Trevisi, Serkan Ateş · 2022 · Journal of Animal Science
Cannabidiol and Neurodevelopmental Disorders in Children
Keith A. Kwan Cheung, Murray David Mitchell, Helen Heussler · 2021 · Frontiers in Psychiatry
Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting
Erin M. Rock, Cheryl L. Limebeer, Roger G. Pertwee, Raphael Mechoulam, Linda A. Parker · 2021 · Cannabis and Cannabinoid Research
Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
Jurga Bernatonienė, Arūnas Ščiupokas, Dalia M. Kopustinskienė, Kęstutis Petrikonis · 2023 · Pharmaceutics
Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance
Mahboubeh Tajaldini, Amirhoushang Poorkhani, Taghi Amiriani, Amirhossein Amiriani, Hossein Javid, Parham Aref, Farahnazsadat Ahmadi, Somayeh Sadani, Vahid Khori · 2023 · European Journal of Pharmacology